Nabriva Therapeutics (NBRVF) Q1 2023 Earnings

11MayExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-5
-4.24
-3.48
-2.72

Details

Expected EPS
-3.37
Actual EPS
-2.7175
Surprise EPS
0.65
Surprise Percent
+19.36%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -2.7175 per share for Q1 2023.

0 Comments

Share your thoughts